We aren’t public health experts, but we have seen how COVID-19 has played out just like everyone else, especially the impact the Delta variant had. With information on Omicron still evolving (and quite rapidly), it’s can be difficult to avoid guessing how Omicron itself is different in order to actually make any decisions.
We’re wrapping up 2021 with anticipated ~50B record high investments in climate tech. Despite the capital rush, we stay disciplined to our market-driven approach, looking for deployable solutions with clear economic incentives.
Will the flood of capital we’re seeing in VC continue? Will it all come crashing down?
While still nascent, V2V is quickly being developed to enable vehicles to wirelessly exchange information.
Currently, the only treatment for hydrocephalus is to place a shunt in order to drain the excess fluid. Patients rely on these shunts for the rest of their lives but shunts are bound to fail. The failure rate is as high as 50% just 18 months after the placement.
In the midst of the global pandemic, the tech industry seems to have woken up. VC funding going into climate change is swelling. We are hearing every week about new funds and approaches to deploying capital into the sector.
Hearing bad startup ideas is an occupational hazard of working in startups or VC. There are some ideas that sound crazy but end up being massive winners. There are other ideas that sound pretty good but end up being duds. And, sometimes, it’s not really about the idea but just one’s own execution and effort—afterContinue reading “One Definite Sign of a Bad Startup”
Moving away from the material transportation uses case discussed in Part II of our series, it’s time to take an even closer look at unregulated spaces where AV technology might find a winner: industrial machines and vehicles already in operation. Since customers will already own these machines (with plenty of life left in them), reinventingContinue reading “Autonomous Vehicle Part III: The Race to Retrofit the Wheel”
In the world of Deep Tech, you can’t use the “move fast and break things” approach. On the bright side, neither can your competitors.
Our team at Creative Ventures invests in technologies that address the inexorable rise in healthcare costs globally. These costs are driven by the secular demographic trend of aging populations and rising chronic disease—and without innovations within healthcare, will force us to face a grim tradeoff of either consuming all of our economic output in maintainingContinue reading “Healthcare Round-Up”